Recursion to Participate in Upcoming Investor Conferences
March 01, 2023 08:00 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...